26 related articles for article (PubMed ID: 38723170)
1. Clinical research of fibroscan ‒ TE-CAP at noninvasive diagnosis of hepatic steatosis in children.
Jia S; Zhou J; Zhang Q; Zhou S; Wang Z; Ye X; Wu J
Clinics (Sao Paulo); 2024; 79():100387. PubMed ID: 38805982
[TBL] [Abstract][Full Text] [Related]
2. Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease.
Yin H; Fan Y; Yu J; Xiong B; Zhou B; Sun Y; Wang L; Zhu Y; Xu H
Insights Imaging; 2024 Jun; 15(1):159. PubMed ID: 38902550
[TBL] [Abstract][Full Text] [Related]
3. A Novel Score Based on Controlled Attenuation Parameter Accurately Predicts Hepatic Steatosis in Individuals With Metabolic Dysfunction Associated Steatotic Liver Disease: A Derivation and Independent Validation Study.
An ZM; Liu QH; Ye XJ; Zhang Q; Pei HF; Xin X; Yuan J; Huang Q; Liu K; Lu F; Yan ZH; Zhao Y; Hu YY; Zheng MH; Feng Q
Clin Transl Gastroenterol; 2024 Mar; 15(3):e00680. PubMed ID: 38240390
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of quantitative ultrasonography for hepatic steatosis in a health screening program: a prospective single-center study.
Pyo JH; Cho SJ; Choi SC; Jee JH; Yun J; Hwang JA; Park G; Kim K; Kang W; Kang M; Byun YH
Ultrasonography; 2024 May; ():. PubMed ID: 38898634
[TBL] [Abstract][Full Text] [Related]
5. Methodology exploration and reproducibility evaluation of TAI and TSI for quantitative ultrasound assessment of hepatic steatosis.
Li X; Sun Z; Liu W; Sun L; Ren J; Xu Y; Yu H; Bai W
Heliyon; 2024 Jun; 10(11):e31904. PubMed ID: 38845969
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance of ultrasonic backscatter parametric and nonparametric statistics in detecting early hepatic steatosis.
Lin CH; Ho MC; Lee PC; Yang PJ; Jeng YM; Tsai JH; Chen CN; Chen A
Ultrasonics; 2024 Jun; 142():107391. PubMed ID: 38936287
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.
Gu J; Liu S; Du S; Zhang Q; Xiao J; Dong Q; Xin Y
Eur Radiol; 2019 Jul; 29(7):3564-3573. PubMed ID: 30899974
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease.
Lee SJ; Kim SU
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):523-530. PubMed ID: 31018719
[TBL] [Abstract][Full Text] [Related]
9. Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
Shin J; Kim MJ; Shin HJ; Yoon H; Kim S; Koh H; Lee MJ
BMC Pediatr; 2019 Apr; 19(1):112. PubMed ID: 30987634
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy.
Jia S; Zhao Y; Liu J; Guo X; Chen M; Zhou S; Zhou J
Front Pediatr; 2021; 9():784221. PubMed ID: 35087774
[No Abstract] [Full Text] [Related]
13. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
Caussy C; Alquiraish MH; Nguyen P; Hernandez C; Cepin S; Fortney LE; Ajmera V; Bettencourt R; Collier S; Hooker J; Sy E; Rizo E; Richards L; Sirlin CB; Loomba R
Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123
[TBL] [Abstract][Full Text] [Related]
14. Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity.
Peng T; Yi X; Lin Y; Dong X; Zhang P; Qiao Z; Li L
J Pediatr Endocrinol Metab; 2024 May; ():. PubMed ID: 38723170
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
